Packaging DNA into th Herpes Simplex Virus Capsid

将 DNA 包装到单纯疱疹病毒衣壳中

基本信息

  • 批准号:
    9904879
  • 负责人:
  • 金额:
    $ 36.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Continuing Grant
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-08-01 至 2003-07-31
  • 项目状态:
    已结题

项目摘要

BrownMCB 9904879Technical Like all herpesviruses, herpes simplex virus 1 (HSV-1) consists of an icosahedral capsid surrounded by a membrane envelope. The virus DNA is contained inside the capsid. Infection with HSV-1 begins when the virus membrane binds to the cytoplasmic membrane of a host cell and fuses with it. Fusion results in introduction of the DNA-containing capsid (the nucleocapsid) into the cytoplasm where it migrates to the nucleus and injects its DNA through a nuclear pore. Virus DNA is then replicated and capsids are assembled in the nucleus. Further virus maturation includes packaging of DNA into a capsid which is enveloped at the inner nuclear membrane before exiting the host cell, a process that may proceed by de-envelopment at the outer nuclear membrane followed by re-envelopment in the cytoplasm. Packaging of HSV-1 DNA into a capsid is required for virus growth. The process involves participation of capsids, concatemeric DNA and the products of eight virus genes, UL6, UL15, UL17, UL21, UL25, UL28, UL32 and UL33. In cells infected with mutants (e.g. ts or null mutants) in any of the eight genes, capsids and HSV-1 DNA accumulate, but no encapsidation is observed. Previous studies have suggested potential roles for some of the eight processing/ packaging proteins. For example, the UL15 and UL28 gene products have been proposed to bind to DNA pac sites and translocate DNA into the capsid in a fuction analogous to that of the large subunit of bacteriophage terminase. The UL6 protein, a minor component of the capsid, may function like the bacteriophage portal or connector protein to mediate attachment of capsids to the terminase homolog. pUL25 may serve as a stopper or cap to keep DNA inside the capsid once it has entered.The goal of this research is to use ultrastructural and biochemical methods to clarify how HSV-1 DNA is encapsidated and how the processing/packaging proteins participate in encapsidation events. Ultrastructural studies will involve electron microscopic examination of HSV-1-infected cells after specific immuno-gold staining for capsid and processing/packaging proteins. It is expected that high resolution (~10 nm) information about the location of a protein in the infected cell nucleus will provide clues about its function. For instance, if pUL15 is involved in DNA translocation into the capsid, then it ought to be found near the site where DNA enters the capsid shell. Similarly, the cap protein should be localized to one particular site on the capsid shell after DNA packaging is complete, but possibly not before. Biochemical studies will be carried out to develop an in vitro system for HSV-1 DNA packaging. Such a system would facilitate more detailed analysis of the encapsidation process by providing the opportunity to manipulate the conditions of packaging outside an infected cell. Efforts to develop an in vitro packaging system will involve lysing infected cells, incubating the lysates and testing for evidence of DNA encapsidation during the incubation period. Evidence for packaging in crude cell lysates will be established before more purified systems are examined. Non-technical In herpes simplex virus 1 (HSV-1), viral DNA is contained inside an icosahedral capsid which in turn is surrounded by a membrane envelope. Infection involves the fusion of viral and host cell cytoplasmic membranes and the introduction of DNA-containing capsid into the cytoplasm. The viral DNA migrates into the nucleus by injection through a nuclear pore. Viral DNA replication and assemblage of the virus take place within the nucleus. A further step for the maturation of the virus is packaging of the newly replicated DNA into viral capsid, which is then enveloped at the inner nuclear membrane before exiting the host cell. This step may proceed by de-envelopment at the outer nuclear membrane followed by re-envelopment in the cytoplasm. A total of eight proteins coded by the virus genome have been identified to involve in these various processes. The goal of this study is to clarify specially how HSV-1 DNA is encapsidated and how some, if not all, of these proteins participate in encapsidation events. High resolution (~10 nm) electron microscopy with specific immuno-gold staining will be used to track these proteins in cells upon infection. This information is expected to provide clues about their function. Biochemical studies will also be carried out to develop an HSV-1 DNA packaging system using reconstituted cell extracts. Such a system would facilitate more detailed analysis of the encapsidation process by providing the opportunity to manipulate the conditions of packaging outside an infected cell.
BrownMCB 9904879技术与所有疱疹病毒一样,单纯疱疹病毒1型(HSV-1)由二十面体衣壳和包膜组成。病毒DNA包含在衣壳内。当病毒膜与宿主细胞的细胞质膜结合并融合时,HSV-1感染开始。融合导致将含有DNA的衣壳(核衣壳)引入细胞质,在那里它迁移到细胞核并通过核孔注入其DNA。然后病毒DNA被复制,衣壳在细胞核中组装。进一步的病毒成熟包括将DNA包装到衣壳中,该衣壳在离开宿主细胞之前在内核膜处被包膜,该过程可以通过在外核膜处脱膜然后在细胞质中再结晶来进行。病毒生长需要将HSV-1 DNA包装到衣壳中。该过程涉及衣壳、多联体DNA和八种病毒基因UL 6、UL 15、UL 17、UL 21、UL 25、UL 28、UL 32和UL 33的产物的参与。在感染了8个基因中任何一个的突变体(例如ts或无效突变体)的细胞中,衣壳和HSV-1 DNA积累,但未观察到衣壳化。先前的研究已经表明了八种加工/包装蛋白中的一些的潜在作用。例如,已经提出UL 15和UL 28基因产物结合到DNA pac位点,并以类似于噬菌体末端酶大亚基的功能将DNA移位到衣壳中。UL 6蛋白是衣壳的次要组分,其功能可能与噬菌体门户或连接蛋白类似,以介导衣壳与末端酶同源物的附着。本研究的目的是利用超微结构和生物化学方法阐明HSV-1DNA是如何被衣壳化的,以及加工/包装蛋白是如何参与衣壳化的。超微结构研究将包括对衣壳和加工/包装蛋白进行特异性免疫金染色后对HSV-1感染细胞进行电子显微镜检查。预计有关蛋白质在感染细胞核中位置的高分辨率(~10 nm)信息将提供有关其功能的线索。例如,如果pUL 15参与DNA易位到衣壳中,那么它应该在DNA进入衣壳壳的位点附近被发现。类似地,在DNA包装完成后,帽蛋白应该定位于衣壳壳上的一个特定位点,但可能不在此之前。将进行生物化学研究以开发用于HSV-1 DNA包装的体外系统。这样的系统将通过提供操纵感染细胞外包装条件的机会来促进更详细地分析腺苷酸化过程。开发体外包装系统的努力将涉及裂解感染的细胞,孵育裂解物并测试孵育期间DNA降解的证据。在检测更纯化的系统之前,将建立在粗细胞裂解物中包装的证据。单纯疱疹病毒1型(HSV-1)的病毒DNA被包含在二十面体衣壳内,二十面体衣壳又被膜包膜包围。感染涉及病毒和宿主细胞质膜的融合以及将含DNA的衣壳引入细胞质中。 病毒DNA通过核孔注射进入细胞核。病毒DNA的复制和病毒的组装发生在细胞核内。病毒成熟的另一个步骤是将新复制的DNA包装到病毒衣壳中,然后在离开宿主细胞之前将病毒衣壳包裹在内核膜处。这一步骤可能是通过外核膜的去核,然后在细胞质中重新核化来进行的。已经鉴定出由病毒基因组编码的总共八种蛋白质参与这些不同的过程。本研究的目的是特别澄清HSV-1 DNA是如何被糖苷化的,以及这些蛋白质中的一些(如果不是全部)是如何参与糖苷化事件的。将使用具有特异性免疫金染色的高分辨率(~10 nm)电子显微镜来追踪感染后细胞中的这些蛋白质。这些信息有望提供有关其功能的线索。 还将进行生物化学研究,以开发使用重组细胞提取物的HSV-1 DNA包装系统。这样的系统将通过提供操纵感染细胞外包装条件的机会来促进更详细地分析腺苷酸化过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jay Brown其他文献

Preventive cardiology and atherosclerotic disease
预防心脏病学和动脉粥样硬化疾病
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    0
  • 作者:
    H. Swan;Jay Brown;M. Davidson;R. Gibbons;D. Levy;F. Meijler;R. Pasternak;T. Pearson;R. Rosenman
  • 通讯作者:
    R. Rosenman
Thermoradiotherapy for persistent cancer in previously irradiated fields
热放射疗法治疗先前照射过的区域中的持续性癌症
  • DOI:
  • 发表时间:
    1986
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    C. Irish;Jay Brown;W. Galen;John J. Gallucci;Milton D. Hyman;I. J. Horowitz;P. Snedecor;H. W. Baker
  • 通讯作者:
    H. W. Baker
SiP Epitaxial Growth for DRAM Bit Contact
  • DOI:
    10.1007/s11664-025-11776-z
  • 发表时间:
    2025-02-14
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Protyush Sahu;Jay Brown;Silvia Borsari;Jeff Hull
  • 通讯作者:
    Jeff Hull
Cocaine-related acute aortic dissection diagnosed by transesophageal echocardiography.
通过经食管超声心动图诊断可卡因相关的急性主动脉夹层。
  • DOI:
    10.1016/0002-8703(94)90289-5
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Ali A. Sherzoy;D. Sadler;Jay Brown
  • 通讯作者:
    Jay Brown
Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance
狗和人肾皮质中的微粒体和细胞溶质缩放因子及其在肾代谢清除率体外外推中的应用
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    D. Scotcher;S. Billington;Jay Brown;Christopher R. Jones;Colin D. A. Brown;A. Rostami;A. Galetin
  • 通讯作者:
    A. Galetin

Jay Brown的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jay Brown', 18)}}的其他基金

Assembly of the Herpes Simplex Virus Capsid
单纯疱疹病毒衣壳的组装
  • 批准号:
    9417770
  • 财政年份:
    1995
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Continuing Grant
Assembly of the Herpes Simplex Virus Capsid
单纯疱疹病毒衣壳的组装
  • 批准号:
    9119056
  • 财政年份:
    1992
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Continuing Grant

相似国自然基金

替尼泊苷抑制APEX1驱动DNA损伤在治疗肺癌中的作用及机制研究
  • 批准号:
    JCZRYB202500477
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
HMGCL通过H3K27乙酰化增强RAD52依赖的DNA损伤修复促进宫颈癌放疗抵抗的机制研究
  • 批准号:
    JCZRLH202500546
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于仿生非平衡态的DNA纳米机器构建及其对多种霉菌毒素高灵敏同步
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于 DNA 编码分子库的新型蛋白抑制剂分子胶水活性评价与机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
复制蛋白A小分子抑制剂-HAMNO调控DNA损伤修复的结构及功能研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于合金@硼烯的比率型折纸电化学芯片构建及其在多种循环肿瘤DNA的超灵敏检测
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
NEDD4泛素化调控CREB/miR-132轴诱发精子DNA碎片化在肥胖不育中的作用及机制
  • 批准号:
    QN25H200016
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
高强度DNA杂化纳米机器人在内体膜调控和核酸药物递送中的基础研究
  • 批准号:
    HDMZ25H300006
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
PLOD2的DNA低甲基化模式驱动内质网与线粒体代谢串扰诱导免疫微环境重塑和化疗耐药
  • 批准号:
    KLY25H160008
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于内在抗炎和抗氧化功能的可注射 DNA 水凝胶高效负载牙髓干细胞促进脊髓损伤修复的作用研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

A genome wide investigation into the roles of error-prone polymerases during human DNA replication
对易错聚合酶在人类 DNA 复制过程中的作用进行全基因组研究
  • 批准号:
    24K18094
  • 财政年份:
    2024
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
DMREF/Collaborative Research: Architecting DNA Nanodevices into Metamaterials, Transducing Materials, and Assembling Materials
DMREF/合作研究:将 DNA 纳米器件构建为超材料、转换材料和组装材料
  • 批准号:
    2323968
  • 财政年份:
    2023
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Standard Grant
SBIR Phase I: Directed evolution of site-specific bacterial transposase genes to alter specificity and efficiency of insertion of large DNA segments into restorable gene fusions
SBIR 第一阶段:位点特异性细菌转座酶基因的定向进化,以改变大 DNA 片段插入可恢复基因融合的特异性和效率
  • 批准号:
    2234291
  • 财政年份:
    2023
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Standard Grant
Rings and Clamps around DNA in Asgard Archaeal cells: Insights into DNA replication and repair from our closest prokaryotic ancestors
阿斯加德古菌细胞中 DNA 周围的环和夹:从我们最接近的原核祖先那里深入了解 DNA 复制和修复
  • 批准号:
    2883516
  • 财政年份:
    2023
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Studentship
DMREF/Collaborative Research: Architecting DNA Nanodevices into Metamaterials, Transducing Materials, and Assembling Materials
DMREF/合作研究:将 DNA 纳米器件构建为超材料、转换材料和组装材料
  • 批准号:
    2323969
  • 财政年份:
    2023
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Standard Grant
New insights into the cellular response to complex DNA damage induced by proton beam therapy
关于质子束治疗引起的复杂 DNA 损伤的细胞反应的新见解
  • 批准号:
    MR/V028944/2
  • 财政年份:
    2023
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
Integrating Epigenetic Modulation into DNA Damage Repair
将表观遗传调节整合到 DNA 损伤修复中
  • 批准号:
    10446970
  • 财政年份:
    2022
  • 资助金额:
    $ 36.75万
  • 项目类别:
Incorporating geography into statistical methods for analysis of population genomic DNA
将地理学纳入群体基因组 DNA 分析的统计方法
  • 批准号:
    10737747
  • 财政年份:
    2022
  • 资助金额:
    $ 36.75万
  • 项目类别:
oxDNA3 - Introducing Sequence-Specific Curvature And Elasticity Into A Coarse-Grained DNA Model
oxDNA3 - 将序列特异性曲率和弹性引入粗粒度 DNA 模型
  • 批准号:
    EP/V06231X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 36.75万
  • 项目类别:
    Research Grant
Site-specific Integration of Large (10-100 kb) DNA Constructs into the Mouse Genome and Human Induced Pluripotent Stem Cells Using the Cas9-Bxb1 Integrase Toolbox
使用 Cas9-Bxb1 整合酶工具箱将大型 (10-100 kb) DNA 构建体定点整合到小鼠基因组和人类诱导多能干细胞中
  • 批准号:
    10522250
  • 财政年份:
    2022
  • 资助金额:
    $ 36.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了